Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

Clinical trial NCT04166474 · COMPLETED

Trial details

NCT number: NCT04166474
Sponsor: Helen Reynolds
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hiv Tuberculosis

Start date: 2021-11-18
Primary completion: 2024-02-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.